IP Library Granted Patent US 11,324,580
Granted Patent B2
US 11,324,580 · App. 16/159,110 · Granted May 10, 2022

Sterile packaging container

Inventors: David Loomis (San Diego, CA); Morton Albert (San Diego, CA)
Assignee: NuVasive, Inc.
A61F2/0095A61L2/081A61L2/206A61L2/26A61L2202/182A61L2202/21B29C48/09B29L2031/712
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,324,580
App. No.
16/159,110
Granted
May 10, 2022
Kind
B2
Abstract

The present disclosure in one aspect provides a sterile packaging container comprising a container body with a cross-sectional shape that is constant along the majority of the longitudinal axis, a cover and a closure assembly that inhibits the passage of microbial contaminants. The container is configured such that the interior of the container can be sterilized. The sterile packaging container described herein allows one to manufacture a sterile packaging tube exercising the smallest possible volume.

Claims (15)

1. A container configured for sterilization and gas permeation, the container comprising:

a container body with a longitudinal axis, a first open end, and a second open end, wherein the container body has a cross-sectional shape that is constant along the majority of the longitudinal axis;

a cover comprising a cover cap and a stopper element, the cover forming a microbe-tight seal on the first open end; and

a closure assembly that forms a microbe-tight seal on the second open end, said closure assembly comprising a closure base attached to the container body at the second open end, and a closure cap removably engaged to the closure base.

2. The container of claim 1 , wherein the external and internal cross-sectional contours of the container body are invariant to one another along a majority of the longitudinal axis.

3. The container of claim 1 , wherein the container body is the product of polymer extrusion.

4. The container of claim 1 , wherein the container body is the product of polymer pultrusion.

5. The container of claim 1 , wherein the stopper element is in a plug engagement with the first open end.

6. The container of claim 1 , wherein the cover forms a hermetic seal with the first open end.

7. The container of claim 1 , wherein the closure base is generally cylindrical with an aperture, and an exterior threaded portion configured to engage the closure cap.

8. The container of claim 7 , wherein the closure cap comprises an internal threaded portion engaged to the exterior threaded portion of the closure base.

9. The container of claim 1 , wherein the closure base and the closure cap form a breathable seal configured to inhibit the passage of bacteria.

10. The container of claim 9 , wherein the breathable seal is configured to inhibit the passage of viruses.

11. The container of claim 1 , comprising a sterile internal volume that is bounded by the container body, the cover, and the closure.

12. The container of claim 1 , wherein said container is constructed of a material that is suitable for sterilization by at least one of: gamma radiation and ethylene oxide.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 27, 2023
From: LOOMIS, DAVID; ALBERT, MORTON
To: NUVASIVE, INC.
Reel/Frame 063105/0596 →
SECURITY INTEREST Recorded Feb 28, 2020
From: NUVASIVE, INC.; NUVASIVE CLINICAL SERVICES MONITORING, INC.; NUVASIVE CLINICAL SERVICES, INC.; NUVASIVE SPECIALIZED ORTHOPEDICS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 052918/0595 →
Continuity (3)
Continuation PCTUS2017027727 · Apr 14, 2017
Provisional Application 62322682 · Apr 14, 2016
Related Publication 20200113666A1 · Apr 16, 2020
Cited By (1)
US 12,502,265